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9 Abstract
10 Motivation. Natural language processing (NLP) techniques are used to extract information automatically from computer-
11 readable literature. In biology, the identification of terms corresponding to biological substances (e.g., genes and proteins) is a
12 necessary step that precedes the application of other NLP systems that extract biological information (e.g., protein–protein in-
13 teractions, gene regulation events, and biochemical pathways). We have developed GPmarkup (for ‘‘gene/protein-full name mark
14 up’’), a software system that automatically identifies gene/protein terms (i.e., symbols or full names) in MEDLINE abstracts. As a
15 part of marking up process, we also generated automatically a knowledge source of paired gene/protein symbols and full names (e.g.,
16 LARD for lymphocyte associated receptor of death) from MEDLINE. We found that many of the pairs in our knowledge source do
17 not appear in the current GenBank database. Therefore our methods may also be used for automatic lexicon generation.
18 Results. GPmarkup has 73% recall and 93% precision in identifying and marking up gene/protein terms in MEDLINE abstracts.
19 Availability: A random sample of gene/protein symbols and full names and a sample set of marked up abstracts can be viewed at
20 http://www.cpmc.columbia.edu/homepages/yuh9001/GPmarkup/. Contact. hy52@columbia.edu. Voice: 718-796-2985; fax: 212-939-
21 7028.
22  2003 Published by Elsevier Science (USA).
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24 1. Introduction
25 The current MEDLINE database includes over 12
26 million computer-readable records in the biomedical
27 domain and is expanding rapidly; it is a rich resource for
28 biological knowledge including protein–protein interac-
29 tions [1], gene regulation events [2], sub-cellular locations
30 of proteins [3], and pathway discovery [4]. One way to
31 automatically extract information stored in MEDLINE
32 is to apply an information extraction system such as a
33natural language processing (NLP) parser [5]. Identify-
34ing gene/protein terms in MEDLINE abstracts is a nec-
35essary step towards an information extraction system.
36Genes and proteins are usually represented by sym-
37bols and names in literature. The names usually are the
38long forms of their symbols and describe the functions
39of the genes or proteins. We hypothesize that authors
40define gene/protein symbols in their articles when the
41meanings are new in literature and the definitions can be
42captured by a computer program. We also hypothesize
43that if not all of the gene/protein symbols appearing in
44an abstract are defined, the definition may appear in
45other abstracts. Therefore literature redundancy (e.g.,
46the same genes or proteins are represented by different
47authors in different articles) makes it plausible that we
48may obtain automatically a relatively exhaustive gene/
49protein symbol and full name table from all of MED-
50LINE. In this study, we empirically tested all of the
51above hypotheses.
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52 This study presents an algorithm and its implemen-
53 tation for automatic identification of gene and protein
54 terms (i.e., symbols or full names) in MEDLINE ab-
55 stracts. As a part of the algorithm, we also present a
56 method for automatically generating a knowledge
57 source of paired gene/protein symbols (e.g., LARD) and
58 full names (e.g., lymphocyte associated receptor of death)
59 from MEDLINE. Our results show that a large number
60 of the pairs in our knowledge source do not appear in
61 LocusLink, a public database of gene/protein symbols
62 and corresponding full names [6,7].
63 A key step in our marking up methodology is to pair
64 gene/protein symbols to their names, so that we can use
65 biological function keywords (e.g., kinase) to differen-
66 tiate the symbols from other technical terms. For ex-
67 ample, by mapping abbreviation PKA to full name
68 protein kinase A, not to full form path of the kinematic
69 axis, we are able to identify PKA is a protein term since
70 keywords protein and kinase appear in the full form of
71 PKA.
72 We previously have developed a method that auto-
73 matically maps biomedical abbreviations to full forms.
74 In this study, we incorporated biological domain
75 knowledge into the method of mapping abbreviations to
76 full forms to enhance the mapping between gene/protein
77 symbols and full names. The biological domain knowl-
78 edge was obtained from manually reviewing published
79 guidelines of the nomenclature of genes and proteins.
80 We then developed a method to differentiate paired
81 gene/protein symbols and full names from other bio-
82 medical abbreviations and full forms.
83 To mark up gene/protein terms in MEDLINE ab-
84 stracts, we first mark up gene/protein symbols and full
85 names when the full names are defined. We then look up
86 a knowledge source to mark up the remaining gene/
87 protein terms. We generate the knowledge source by
88 extracting all pairs of gene/protein symbols and full
89 names from over eleven million MEDLINE records
90 (year 1966–2001).
91 2. Background
92 A number of rule-based, linguistic, statistical, ma-
93 chine-learning, and hybrid approaches have been de-
94 veloped to mark up gene/protein terms automatically in
95 biological text. For example, Fukuda et al. (1998) ap-
96 plied morphological cues to identify protein terms (e.g.,
97 if a word contains uppercase letter(s) and special char-
98 acter(s), the word is a protein term). Gaizauskas et al.
99 (2000) identified protein terms through suffixes such as –
100 ase. Proux et al. (1998) identified non-English words as
101 gene terms. Linguistic approaches have mainly applied
102 part-of-speech tagging [8] or shallow parsing [9] to
103 identify noun phrases, from which gene/protein terms
104 were obtained. Hybrid approaches have combined lin-
105guistic with rule-based approaches for multi-word gene/
106protein term recognition. For example [8], applied Brills
107tagger [10] in combination with rules such as ‘‘connect
108non-adjacent annotations if every word between them is
109either noun, adjective, or a numeral’’ to identify multi-
110word protein terms such as ras guanine nucleotide ex-
111change factor SOS. Tanabe and Wilbur [11] retrained
112Brills tagger on the biomedical domain for gene/protein
113name-identification. Statistical approaches have clus-
114tered abstracts for keyword identification [12]. Machine-
115learning approaches have applied na€ıve Bayes [9], Hid-
116den Markov Models [13], and decision trees [14], to
117classify gene/protein terms. Other approaches include
118lookup in knowledge sources such as GenBank and
119SWISSPROT [15].
120Our method of marking up gene/protein names is a
121mixture of pattern-recognition and knowledge-based
122approaches. We first map gene/protein symbols to full
123names when the full names are defined. Those gene/
124protein terms are then marked up. The rest of gene/
125protein terms are identified from the gene/protein sym-
126bol and full name knowledge source which we extracted
127automatically from MEDLINE.
1282.1. Systems that automatically map gene and protein
129symbols to full names
130A number of systems have been developed for auto-
131matic mapping between abbreviations and full names
132[16–23]. Those systems applied a variety of approaches
133including linguistic, rule, and statistical methods and
134reported precisions from 70–97%. Most of those systems
135tend to be domain independent and therefore may not
136perform ideally in a restricted domain such as biology.
137For example, most of pattern-recognition approaches
138[18,19] do not capture ryk (for receptor tyrosine kinase
139related gene) since y represents tyrosine and y is not the
140first letter of tyrosine. In addition, most of the systems
141do not differentiate gene/protein symbols from other
142abbreviations and full names.
143A system that was developed specifically for mapping
144protein symbols to full names is PNAD-CSS (for ‘‘pro-
145tein full name abbreviation dictionary construction
146support system’’) [24]. PNAD-CSS used morphological
147features to recognize proper nouns as protein terms in
148biological abstracts [8]. Knowing a phrase may contain a
149protein symbol and full name, PNAD-CSS recognized
150parentheses and determined whether the parenthetical
151phrase was an abbreviation of the outer phrase. To map
152a protein symbol to its name, PNAD-CSS broke up
153words of the preceding phrase, and determined whether
154the parenthetical abbreviation candidate maps to the
155initial letters of the broken-up phrase. For example,
156consider the phrase ‘‘megestrol acetate (megace).’’
157PNAD-CSS parsed ‘‘megestrol acetate’’ as ‘‘meges trol ac
158etate,’’ which is then matched to ‘‘megace.’’ For example,
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159 ‘‘meg,’’ ‘‘ac,’’ and ‘‘e’’ in ‘‘megace’’ match the initial
160 letter(s) of ‘‘meges,’’ ‘‘ac,’’ and ‘‘etate,’’ respectively.
161 We find that PNAD-CSS has some limitations: it
162 applies morphological cues for protein term recognition
163 and the morphological cues may falsely identify as
164 protein symbols other substances (e.g., LSD-25 for ly-
165 sergic acid diethylamide), cell types (e.g., BHK-21 for
166 baby-hamster kidney-cell line), procedures (e.g., PCR for
167 polymerase chain reaction) as well as clinical syndromes
168 and diseases (e.g., CHF for congestive heart failure). This
169 is because many abbreviations that are not gene/protein
170 symbols consist of upper-case letters and numbers. The
171 PNAD-CSS pattern-matching rules also did not contain
172 special rules for protein names (for example, y repre-
173 sents tyrosine).
174 Previously, we have developed a system, AbbRE (for
175 ‘‘abbreviation and full name recognition and extrac-
176 tion,’’ see [25]), that pairs biomedical abbreviations with
177 full names. AbbRE first selected parenthetical expres-
178 sions and the phrases preceding the parenthesis as can-
179 didate abbreviations and full names. It then applied a set
180 of the pattern-matching rules to map abbreviations to
181 full names. The rules were obtained from the common
182 conventions authors use to create abbreviations. The
183 following rules were included: (1) the first letter of an
184 abbreviation matches the first letter of a meaningful word
185 of the full name; (2) the abbreviation matches the first
186 letter of each word in the full name; (3) the abbreviation
187 letter matches consecutive letters of a word in the full
188 name and (4) the abbreviation letter matches a middle
189 letter of a word in the full name if the first letter of the
190 word matches the abbreviation. AbbRE had 70% recall
191 and 95% precision in identifying paired abbreviations
192 and full names in biomedical articles.
193 Though AbbREs pattern-matching rules did not
194 contain special rules for protein names, AbbRE is robust
195 and extensible. In this study (i.e., GPmarkup), we man-
196 ually examined the published guidelines of the nomen-
197 clature of genes and proteins and added toAbbRE special
198 rules to enhance its mapping gene/protein symbols to full
199 names. In addition, we added in rules for differentiating
200 gene/protein terms from other biomedical terms.
2013. Methods and results
202Our method section consists of six sub-sections: (1)
203Mapping gene/protein symbols to full names as well as
204abbreviations to full names. (2) Generating a knowledge
205source of paired abbreviations and full names from
206MEDLINE abstracts. (3) Filtering out other abbrevia-
207tion-full name pairs to produce a knowledge source of
208paired gene/protein symbols and full names. (4) Mark-
209ing up gene/protein terms in MEDLINE abstracts. (5)
210Evaluating GPmarkup. (6) Measuring the percentage of
211defined gene/protein symbols in MEDLINE abstracts.
2123.1. Mapping gene/protein symbols to full names
213To understand how gene/protein abbreviation-full
214name pairs are created in the first place, we examined a
215number of published guidelines for the nomenclature of
216genes and proteins. We found those guidelines are al-
217most always species-specific (that is applicable only to
218genes and proteins from, say, yeast, and not rat). Spe-
219cies-specific may be caused by the fact that the com-
220mittees for the nomenclature are formed by experts
221specializing on a particular model organism. Table 1
222lists guidelines that were useful for mapping abbrevia-
223tions to full forms.
224Analysis of the published guidelines allowed us to
225identify some special abbreviations that are used for
226gene/protein nomenclature (see Table 2) and to develop





232GPmarkup applies a set of pattern-matching rules to
233map gene/protein symbols to full names when the full
234names are defined within the documents. The pattern-
235matching rules adapted AbbREs (as described in Sec-
236tion 2.1) with the following modifications and exten-
237sions:
Table 1
Guidelines that are useful for applying computational approaches to map a gene or a protein symbol to its full name
1. A gene symbol should stand for a description of a phenotype, a gene product or a gene function [26].
2. A gene symbol shall be short (between three to six characters) [26–32].
3. A gene symbol is an abbreviation of its full name [28].
4. If the symbol of a gene contains a character or property for which there is a recognized abbreviation, the abbreviation should be used; for
example, the single-letter abbreviation for amino acids used in aminoacyl residues or approved biochemical Abbreviations such as GLC for
glucose, GSH for glutathione [31] and Bp for binding protein [32].
5. The initial character should always be a letter [29–33].
6. All Greek symbols should be changed to letters in the Latin alphabet [31].
7. Amino acids have their special symbols [34].
8. The protein symbol is the same as the gene symbol [33].
9. The creator of a gene full name shall follow the guidelines and get consultation from curator of the guideline before journal publication [26].
10. Gene full names should be included in the abstracts of any relevant papers [26].
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238 Rule 1: Any number and special character is ignored
239 for mapping gene/protein symbols to full names.
240 We added in a rule to map letters only. We ignored
241 numbers and special characters (e.g., ‘‘+’’) due to the
242 following two reasons:
243 (1) Many numbers and special characters in a gene or a
244 protein symbol do not appear in their full names.
245 For example, CYP2C19 for cytochrome P450, sub-
246 family IIC (mephenytoin 4-hydroxylase), where
247 ‘‘19’’ is not represented and ‘‘2’’ is represented by
248 ‘‘II.’’
249 (2) Many numbers in gene or protein symbols order dif-
250 ferently in their full names (e.g., ALOX12 for ara-
251 chidonate 12-lipoxygenase, where ‘‘12’’ in the
252 symbol ‘‘ALOX12’’ is after ‘‘LOX’’ that represents
253 lipoxygenase, but before ‘‘lipoxygenase’’ in the full
254 name ‘‘arachidonate 12-lipoxygenase’’).
255 Rule 2: Special abbreviation substitutions
256 We substitute some nouns with their special abbre-
257 viations when we apply the pattern-matching rules. For
258 example, instead of mapping DYRK1A to dual-specific-
259 ity tyrosine phosphorylation regulated kinase 1A, we at-
260 tempt to map DYRK1A to dual-specificity Y
261 phosphorylation regulated kinase 1A, where tyrosine has
262 been replaced by Y. After the mapping, we recover the
263 original terms.
264 In reality, not all the authors use the special abbre-
265 viations (listed in Table 2) for their nomenclature. An
266 example is PTK2B for protein tyrosine kinase 2 b, where
267 tyrosine is represented by its common abbreviation T
268 instead of Y. Therefore, our algorithm considers both
269 types of mapping (with and without substitution of a
270 special noun with a shorthand) and selects the best
271 matching version.
272 For example, we attempt to map PTK2B to both
273 protein tyrosine kinase 2 b and protein Y kinase 2 b; we
274 map DYRK1A to both dual-specificity tyrosine phos-
275 phorylation regulated kinase 1A and dual-specificity Y
276 phosphorylation regulated kinase 1A.
277 When a full name has more than one word that has
278 many abbreviations, we include all of the combinations
279 for substitution. For example, in case of NK AIF for
280 sodium–potassiumATPase inhibitory factor, we attempted
281 to map NKAIF to sodium–potassium ATPase inhibitory
282 factor, Na–potassium ATPase inhibitory factor, sodium–K
283 ATPase inhibitory factor, and Na–K ATPase inhibitory
284factor. We found that Na–K ATPase inhibitory factorwas
285mapped and we recovered the original full name.
2863.1.3. Parenthetic pattern
287Prior to pattern-matching rules, GPmarkup selects
288candidate abbreviations and full names. For this task,
289GPmarkup recognizes special patterns such as ‘‘<ab-
290breviation>(<full name>)’’ or ‘‘<full name>(<abbrevi-
291ation>)’’. Recall AbbRE also recognized these patterns.
292However, AbbRE can not recognize gene/protein terms
293that incorporate nested parentheses. For example, Ab-
294bRE fails to map acyl-coenzyme A (acyl-CoA) dehydro-
295genases to ACD from the following string extracted
296from [35] the expression of various acyl-coenzyme A
297(acyl-CoA) dehydrogenases (ACD) since it parses into
298the following two components:
299the expression of various acyl-coenzyme A (acyl-CoA) and dehy-
300drogenases (ACD)
301To correct for this shortcoming, we introduced into
302the newer algorithm (GPmarkup) an additional rule to
303recognize gene/protein full names that incorporate pa-
304rentheses. It then parses the above string into the fol-
305lowing two components:
306the expression of various acyl-coenzyme A (acyl-CoA) and the ex-
307pression of various acyl-coenzyme A (acyl-CoA) dehydrogenases
308(ACD)
309where the phrases preceding and within the parentheses
310in each component incorporate candidate abbreviations
311and full names, to which GPmarkup further applies its
312pattern-matching rules to map abbreviations to full
313names.
3143.2. Generating a knowledge source of paired abbrevia-
315tions/full names from MEDLINE abstracts
316We applied GPmarkup to 11 million MEDLINE re-
317cords (1966–2001), which contain the same number of
318titles and over six million abstracts (note that not all
319MEDLINE records contain abstracts). We obtained a
320knowledge source that consisted of 574,327 unique pairs
321of abbreviations and full names. The most frequently
322defined abbreviations were PCR (polymerase chain re-
323action, which appeared in 7988 abstracts) and NO (nitric
324oxide, which appeared in 7855 abstracts).
Table 2
Special abbreviations that are used in gene/protein nomenclature
Type




Sodium–Na, potassium–K (NKAIF for sodium–potassium ATPase inhibitory factor)
Three other
symbols used
Inhibitor—N or NH, box—X (CDKN1A for cyclin-dependent kinase inhibitor 1A (p21, Cip1), CDX1 for caudal type homeo
box transcription factor 1)
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325 3.3. Filtering out other abbreviation-full name pairs to
326 produce a knowledge source of paired gene/protein
327 symbols and full names
328 The algorithm outlined above also identifies a large
329 number of general abbreviations that are not gene/pro-
330 tein symbols and full names. We therefore developed a
331 rule-based approach to partition our knowledge source
332 of abbreviation-full name pairs into gene/protein sym-
333 bol-full name pairs and other abbreviation-full name
334 pairs.
335 Our rule-based approach combines morphological
336 cues, functional keywords, and position-functional
337 keywords to filter out non-gene/protein terms. The ap-
338 proach is described as follows:
339 If an abbreviation contains a number, the abbrevia-
340 tion and full name is a gene/protein symbol-full name
341 pair only if the full name contains one or more of the
342 following keywords (denoted as set K1): protein(s),
343 gene(s), peptide(s), molecule(s), enzyme(s), ligand(s),
344 compound(s), receptor(s), channel(s), transcriptor(s),
345 regulator(s), inhibitor(s), antibody, antibodies, globu-
346 lin(s), factor(s), motif, domain(s), compound(s), seg-
347 ment(s), subunit(s), locus, loci, cassette(s), chain,
348 complex(es), homeobox(es), box(es), member(s), dele-
349 tion, axon, family, families, chromosome(s), sequence,
350 a, b, c, interleukin and any words except for disease
351 that ends in –ase.
352 If an abbreviation does not contain a number, the ab-
353 breviation and full name is gene/protein symbol-full
354 name pair only if the last word of the full name is a
355 keyword in set K1.
356 We obtained functional keywords by manually ex-
357 amining all of the entries in LocusLink. Note that some
358 keywords (e.g., ‘‘gene’’) in set K1 can appear as both the
359 last word or the middle word of a gene/protein term
360 (e.g., Btg4 for B-cell translocation gene 4 and AFG3L1
361 for AFG3 (ATPase family gene 3, yeast)-like 1). On the
362 other hand, some keywords (e.g., ‘‘chromosome’’) do
363 not appear as the last word of, but only within a gene/
364 protein term (e.g., C10ORF2 for chromosome 10 open
365 reading frame 2).
366 We applied the rules to abbreviations and full names
367 and generated a knowledge source of 86,767 unique
368 pairs of gene/protein symbols and full names. The most
369 frequently defined gene/protein symbols included egf
370 (for epidermal growth factor, appears in 2023 ab-
371 stracts), il (for interleukin, appears in 2183 abstracts),
372 and ldl (for low density lipoprotein, appears in 2673
373 abstracts).
374 3.4. Marking up gene/protein terms in MEDLINE
375 abstracts
376 We further developed and implemented an algorithm
377 to mark up gene/protein terms in MEDLINE abstracts.
378GPmarkup first maps abbreviations to full names and
379then performs the markup for any abbreviation with an
380identified full name (details in Sections 3.2 and 3.3). For
381the remaining terms in abstracts, we looked up the
382knowledge sources of paired abbreviations and full
383names and paired gene/protein symbols and names. As
384an effort to achieve a higher precision, we only looked
385up multi-word gene/protein terms, since a single word
386term could be ambiguous (for example, aap denotes
387antiarrhythmic peptide or automatic action potential, the
388former is a protein name, and the latter is not).
389When a string can be mapped to several terms stored
390in our knowledge sources, GPmarkup favors longer
391term mapping and markup. It does not mark up a term
392which is used as a modifier of entity other than genes
393and proteins. For example, GPmarkup does not markup
394the protein term amyloid b protein in a string of cerebral
395amyloid b protein angiopathy, because the protein name
396is used as a modifier for the disease term angiopath.
397GPmarkup applies direct matching (i.e., the string in
398text exactly appears in our knowledge sources) except
399that GPmarkup includes a word that immediately fol-
400lows a gene or a protein symbol or full name if the word
401either consists of a number or is a functional keyword
402including ‘‘gene,’’ ‘‘protein,’’ ‘‘homologue,’’ and ‘‘re-
403ceptor.’’ For example, knowing a b and il12 p40 as gene
404or protein symbols, GPmarkup also identifies a b40 and
405il12 p40 homologue.
4063.5. GPmarkup evaluation
407We performed evaluation in the following three
408steps: (1) mapping abbreviations to full names, (2) fil-
409tering out other terms to produce a knowledge source
410of paired gene/protein symbols and names, and (3)
411marking up gene/protein terms in MEDLINE ab-
412stracts. We therefore evaluate GPmarkup phase by
413phase. We also compared the knowledge source of
414paired gene/protein symbols and full names with the
415ones in LocusLink. We evaluated by recall (i.e., num-
416ber of correct answers identified by our system divided
417the total number of correct answers) and precision (i.e.,
418number of correct answers divided by the total number
419of answers specified by our system). We estimated
420confidence intervals for these measures based on the
421binomial distribution.
4223.5.1. Mapping abbreviations to full names
423We randomly (by time of publication) selected 30
424MEDLINE abstracts and asked three biomedical ex-
425perts (all with PhD or MD) to map abbreviations to full
426names when the full names are defined within the ab-
427stracts. The gold standard was determined by a majority
428vote of experts. GPmarkup correctly mapped 56 ab-
429breviations and full names out of a total of 59 pairs that
430were determined by experts. GPmarkup wrongly iden-
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431 tified one pair that was not an abbreviation and full
432 name. GPmarkups recall and precision in identifying
433 and extracting abbreviations and full names were, with
434 95% confidence intervals, 0.95 (0.86–0.99) and 0.98
435 (0.91–1.00), respectively.
436 3.5.2. Filtering out other terms
437 We then evaluated our rule-based approach for par-
438 titioning the knowledge source of abbreviation-full name
439 pairs into gene/protein symbol-full name pairs and other
440 abbreviation-full name pairs. We randomly selected 1000
441 pairs of gene/protein symbols and full names and 1000
442 pairs of other abbreviations and full names partitioned
443 by GPmarkup and evaluated recall and precision of the
444 partitioning. We asked experts (see 3.5.1) for help in
445 defining a gold standard. Table 3 lists the results of the
446 evaluation. Note that GPmarkup included some in-
447 complete-matches of abbreviations and full names (e.g.,
448 {il-6, interleukin}). Since the ratio of gene/protein sym-
449 bol-names to other abbreviation-full name pairs was
450 1:5.6 (86,767/[574,327–86,767]); the numbers were de-
451 scribed in Sections 3.2 and 3.3), GPmarkup had an ac-
452 curacy of 0.95 0.02, with 95% confidence. The figure
453 0.95 comes from the ratio ð982þ 949  5:6Þ=ð1000þ
454 1000  5:6Þ which is based on the numbers in Table 3
455 and their relative frequencies as just computed.
456 3.5.3. Marking up gene/protein terms in MEDLINE
457 abstracts
458 We then evaluated GPmarkup in marking up gene/
459 protein terms in MEDLINE abstracts. We randomly (by
460 time of publication) selected 50 MEDLINE abstracts,
461 which consists of a total of 539 sentences (including the
462 title). Some selected abstracts did not cover biological
463 domain and therefore did not have gene/protein terms at
464all. Therefore, we did not select only biological abstracts
465for evaluation because we judge a false markup is as bad
466as a missing markup. We therefore judged that a ran-
467dom selection of abstracts best reflects our systems re-
468call and precision.
469Table 4 lists the evaluation results of the 50 abstracts.
470GPmarkup applies XML format for term mark up. For
471example, the tag ‘‘phr’’(for ‘‘phrase’’) has attributes in-
472cluding ‘‘sem’’ (for ‘‘semantic category’’) that has value
473‘‘gp’’ (for ‘‘gene and protein terms’’) and ‘‘t’’ (for ‘‘tar-
474get’’) that represents gene/protein full names. We count
475any appearance of gene/protein terms. For example, if
476protein ‘‘amyloid b protein’’ appears three times in the
477abstract, we count three instead of one for this case. We
478posted a sample set of marked up abstracts at http://
479www.cpmc.columbia.edu/homepages/yuh9001/GPmark-
480up/).
481From Table 4, if we count a partial-matching as a
482match, the recall and the precision of GPmarkup were,
483with 95% confidence, 0.73 0.05 ð222þ 15Þ=ð222þ
48415þ 88Þ and 0.93 0.03 ð222þ 15Þ=ð222þ 15þ 17Þ,
485respectively. We found all partial matches represent valid
486proteins. However, if we do not include a partial-match-
487ing as a match, the recall and precision of GPmarkup
488were, with 95% confidence, 0.68 0.05 222=ð222þ 15þ
48988Þ and 0.87 0.04 ð222=ð222þ 15þ 17Þ, respectively.
4903.5.4. Comparing gene/protein symbols and full names
491extracted from MEDLINE with LocusLink
492We downloaded the knowledge source of paired gene/
493protein symbols and full names from LocusLink [36].
494LocusLink is maintained by the National Center for
495Biotechnology Information. It presents information on
496official nomenclature of genes and lists a total of 115,890
497manually annotated paired gene symbols and full
Table 3
Evaluation results of GPmarkup in filtering the knowledge source of paired abbreviations and full names to produce a knowledge source of paired
gene/protein symbols and full names





Number of non abbreviation-full
name pairs
1000 pairs of gene/protein symbols and
full names as identified by GPmarkup
982 9 (e.g, srg for spent restau-
rant grease)
9 (e.g., gene for genes)
1000 pairs of other abbreviations and
full names as identified by GPmarkup
1 (i.e., A-Igg for
Anti-human Igg)
949 50 (e.g., ph2 for phages)
Table 4
Evaluation results of GPmarkup
Type of category GPmarkup identified
Complete-matching (e.g., <phr sem¼ ‘‘gp’’ t¼ ‘‘signaling lymphocyte activation molecule’’>slam</phr> 222
Partial-matchinga (e.g., <phr sem¼ ‘‘gp’’>interleukin 1</phr> receptor ii) 15
Missing (e.g., 2b4) 88
False-matchingb (e.g., <phr sem¼ ‘‘gp’’>acupuncture points and channels</phr>) 17
a The correct full name is ‘‘interleukin 1 receptor ii’’.
b False-matching includes those non-gene and non-protein terms that are identified by GPmarkup.
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498 names, though we found that only 65,987 entries have
499 both gene/protein symbols and full names.
500 We randomly selected 100 entries that incorporate
501 both symbols and full names from the LocusLink and
502 manually identify their existence in our knowledge
503 source of paired gene/protein symbols and full names.
504 We also randomly selected 100 unique gene/protein
505 symbol and full name pairs from our knowledge source
506 and manually identified their existence in LocusLink.
507 We found that 62 out of 100 selected pairs in our
508 knowledge source did not appear in LocusLink. Exam-
509 ples included {ACY1-ACP, acyl-acyl carrier protein},
510 {GCDFP, gross cyst disease fluid protein}, {CCK-OP,
511 cholecystokinin octopeptide} and {l-PK, l pyruvate ki-
512 nase} though some of the missing pairs represent protein
513 products instead of direct genes. For example, {l-PK, l
514 pyruvate kinase} is a spliced product of its gene {PKLR,
515 pyruvate kinase},2 which appears in LocusLink and there
516 is no gene for {CCK-OP, cholecystokinin octopeptide}.3
517 Eight pairs partially matched to LocusLink. For exam-
518 ple, PPI, peptide prolyl cis trans isomerase appears in our
519 knowledge source. In LocusLink, we found {PPIa,
520 peptidylprolyl isomerase a (cyclophilin a)}.’’
521 On the other hand, we found that only 40 LocusLink
522 entries could be found in our knowledge source (16 of
523 them have variations). We judged that four of those 60
524 failed entries are not gene/protein symbols and full
525 names (e.g., {shs, sutherland-haan x-linked mental re-
526 tardation syndrome}). To find whether the remaining 56
527 entries exist in MEDLINE, we searched 12 million
528 MEDLINE records (1966–2002). We applied direct
529 matching (case insensitive) and manually analyzed ab-
530 stracts that contained either the symbol or the full name
531 of those 56 failed entries. We failed to find the existence
532 of 50 of them in MEDLINE, either symbols or full
533 names. Examples include {2700088m22rik, riken cdna
534 2700088m22 gene} and {atp5bl1, atp synthase, h+
535 transporting, mitochondrial f1 complex, b polypeptide-
536 like 1}. Of the rest of six entries, we could find symbols
537 in MEDLINE, but failed to find full names. Examples
538 include {aspa, aspartoacylase (aminoacylase 2, canavan
539 disease)} and {assp6, argininosuccinate synthetase
540 pseudogene 6}, for the former we found the full name
541 with variations, for the latter we found that the full
542 name did not exist in the MEDLINE record where the
543 symbol appeared.
544 3.6. The percentage of undefined gene/protein symbols and
545 full names
546 If all the gene/protein symbols and full names were
547 defined in MEDLINE abstracts, then GPmarkup would
548also serve the purpose for disambiguation by assigning
549full names to symbols. However, not all the gene/protein
550symbols are defined in the abstracts.
551We measured the percentage of defined gene/protein
552symbols in MEDLINE abstracts. We randomly selected
553100 abstracts (according to the time of publication) from
554a total of 782,560 MEDLINE abstracts (1966–2001)
555that were retrieved by the keyword ‘‘protein.’’ Those
556abstracts contain 1069 sentences (including titles). We
557measured the percentage of undefined gene/protein
558symbols. We counted unique appearance of gene/protein
559symbols within abstracts. Based on the authors judg-
560ment, the numbers of defined and undefined gene/pro-
561tein symbols were 92 and 27, respectively. The
562percentage of defined gene/protein symbols and full
563names was, with 95% confidence, 0.77 0.08.
5644. Discussion
565Many public databases such as GenBank have gene/
566protein synonym knowledge sources. However, the da-
567tabases are largely maintained manually and therefore
568are not always up to date. GPmarkup can generate
569automatically a knowledge source of paired gene/protein
570symbols and full names from MEDLINE abstracts. The
571automated fashion may reduce manual efforts. In addi-
572tion, GPmarkup may capture the most up-to-date gene/
573protein symbols and full names if the full names are
574defined in abstracts and follow the guidelines of no-
575menclature of genes and proteins.
576We also found that a majority of gene/protein sym-
577bols and full names extracted in our knowledge source
578did not appear in LocusLink. Recall LocusLink consists
579of a large number of mainly manually annotated paired
580gene/protein symbols and full names. In addition, we
581found a majority of pairs in LocusLink did not appear
582in our knowledge source either; most of those pairs did
583not even appear in MEDLINE by keyword search. The
584results suggest that there is a gap between LocusLink
585knowledge source and the actual text. This difference
586may make it difficult to apply LocusLink directly for
587looking up terms in MEDLINE. On the other hand,
588since our knowledge source of paired gene/protein
589symbols and names were directly extracted from
590MEDLINE, they may be more useful as a knowledge-
591based markup.
592One limitation of GPmarkup is that not all the gene/
593protein symbols and full names are defined in the ab-
594stracts and therefore GPmarkup may not capture some
595gene/protein symbols and full names. However, two
596other factors alleviate this problem: authors are en-
597couraged to define gene/protein full names in the ab-
598stracts of any relevant papers [26], and the literature is
599redundant. Therefore, applying GPmarkup to all of
600MEDLINE abstracts is likely to capture a majority of
2 GenBank Accession No. U47654.
3 For details see http://arbl.cvmbs.colostate.edu/hbooks/pathphys/
endocrine/gi/cck.html).
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601 gene/protein symbols and full names that appear in the
602 text.
603 GPmarkup may also miss gene/protein symbols and
604 full names when authors do not follow the guidelines for
605 naming genes and proteins. To capture these gene/pro-
606 tein symbols and full names, we may integrate into
607 GPmarkup statistical approaches such as Hisamitsu and
608 Niwas approach [18,20] of selecting phrases associated
609 with parentheses that were statistically significant. In
610 addition, GPmarkup may also miss abbreviations and
611 full names that are introduced through syntactic pat-
612 terns (e.g., appositions). In the near future we plan to
613 utilize the approaches of [37] that enumerated syntactic
614 patterns for abbreviation detection.
615 Other limitations include the ambiguity in usage of
616 gene/protein terms. For example, we do not differentiate
617 a gene term from a protein one. We do not differentiate
618 a general gene/protein term (e.g., growth factors) from a
619 specific one (e.g., protein kinase A). We also do not
620 identify to which organism, tissue, cell type, and sub-
621 location a gene/protein term refers. We propose to in-
622 tegrate the approach of [38] for disambiguating gene/
623 protein terms. We also hope to develop statistical NLP
624 approaches for further disambiguation.
625 Our study shows that many gene/protein symbols
626 (77%) are defined within the abstracts, GPmarkup can
627 map a majority of gene/protein symbols to full names.
628 GPmarkup does not mark up undefined gene/protein
629 symbols if the symbols have several full names in the
630 knowledge source of abbreviation-full name pairs. For
631 example, aap denotes antiarrhythmic peptide, alkyl ac-
632 ceptor protein, alzheimer amyloid precursor protein, am-
633 inoantipyrine, and automatic action potential in our
634 knowledge source and GPmarkup thus does not mark
635 up ‘‘aap’’ as a gene/protein term when it is not defined in
636 the abstract. We therefore sacrifice GPmarkups recall
637 for high precision. In the future, we will integrate a
638 disambiguation method that assigns the full names from
639 our knowledge source to the ambiguous symbols. Once
640 a symbol is assigned to its full name, we can apply our
641 rule-based approach (see Section 3.3) determining whe-
642 ther the symbol is a gene/protein term.
643 Note that we recognized a gene/protein term if the
644 term actually represents a gene/protein in the abstract.
645 We described earlier that we did not mark up ‘‘cerebral
646 amyloid b protein angiopathy’’ as a protein name even
647 though ‘‘cerebral amyloid b protein’’ by itself is a protein
648 name. Other researchers may do differently [11].
649 5. Conclusion
650 This study shows that GPmarkup is efficient (73%
651 recall and 93% precision) in marking up gene/protein
652 terms in MEDLINE abstracts. Our results may provide
653 a useful supplement to manually curated resources such
654as LocusLink (GenBank). A method to more accurately
655identify the full names of undefined abbreviations would
656increase the recall of GPmarkup and enhance its use-
657fulness.
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